National Graham Number from 2010 to 2024

NHI Stock  USD 70.63  1.79  2.60%   
National Health's Graham Number is increasing with very volatile movements from year to year. Graham Number is predicted to flatten to 26.02. For the period between 2010 and 2024, National Health, Graham Number quarterly trend regression had mean deviation of  11.95 and range of 52.6424. View All Fundamentals
 
Graham Number  
First Reported
2010-12-31
Previous Quarter
45.08898286
Current Value
26.02
Quarterly Volatility
15.0503581
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check National Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among National Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 36.5 M, Interest Expense of 58.3 M or Total Revenue of 170.8 M, as well as many indicators such as Price To Sales Ratio of 7.26, Dividend Yield of 0.0868 or PTB Ratio of 1.84. National financial statements analysis is a perfect complement when working with National Health Valuation or Volatility modules.
  
Check out the analysis of National Health Correlation against competitors.

Latest National Health's Graham Number Growth Pattern

Below is the plot of the Graham Number of National Health Investors over the last few years. It is National Health's Graham Number historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in National Health's overall financial position and show how it may be relating to other accounts over time.
Graham Number10 Years Trend
Very volatile
   Graham Number   
       Timeline  

National Graham Number Regression Statistics

Arithmetic Mean38.89
Geometric Mean30.18
Coefficient Of Variation38.70
Mean Deviation11.95
Median45.09
Standard Deviation15.05
Sample Variance226.51
Range52.6424
R-Value0.10
Mean Square Error241.44
R-Squared0.01
Significance0.72
Slope0.34
Total Sum of Squares3,171

National Graham Number History

2024 26.02
2023 45.09
2022 18.13
2021 31.77
2020 48.02
2019 43.15
2018 52.37

About National Health Financial Statements

Investors use fundamental indicators, such as National Health's Graham Number, to determine how well the company is positioned to perform in the future. Although National Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Graham Number 45.09  26.02 

Currently Active Assets on Macroaxis

When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:
Check out the analysis of National Health Correlation against competitors.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.14)
Dividend Share
3.6
Earnings Share
2.91
Revenue Per Share
7.598
Quarterly Revenue Growth
(0.12)
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.